Myricetin-loaded SBA-15 silica nanoparticles for enhanced management of pyrexia, pain, and inflammation through modulation of MAPK/NF-κB and COX-2/PGE-2 pathways: Evidence from the biochemical, histological, and metabolomic analysis
- 30 September 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 666, 124775
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MSInflammopharmacology, 2024
- Preparation of myricetin nanoliposomes using film-ultrasonic dispersion method and characterizationApplied Nanoscience, 2022
- Protocatechuic acid counteracts oxidative stress and inflammation in carrageenan-induced paw edema in miceEnvironmental Science and Pollution Research, 2022
- Anti‐inflammatory effects of cordycepin: A reviewPhytotherapy Research, 2020
- Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspectiveBiochemical Pharmacology, 2020
- Nanoarchitectured Structure and Surface Biofunctionality of Mesoporous Silica NanoparticlesAdvanced Materials, 2020
- Nutrition interventions to treat low muscle mass in cancerJournal of Cachexia, Sarcopenia and Muscle, 2020
- Myricetin attenuated LPS induced cardiac injury in vivo and in vitroPhytotherapy Research, 2017
- Revealing anti-inflammation mechanism of water-extract and oil of forsythiae fructus on carrageenan-Induced edema rats by serum metabolomicsBiomedicine & Pharmacotherapy, 2017
- Application of Mesoporous Silicon Dioxide and Silicate in Oral Amorphous Drug Delivery SystemsJournal of Pharmaceutical Sciences, 2012